Olivier Bosc is the new Chief Executive officer at Eurobio Scientific

In EXEC
Wed, 8 Nov 2023

Olivier Bosc embarks on an exhilarating journey as the newly appointed Deputy Chief Executive Officer at Eurobio Scientific, eager to contribute to the company's human and growth endeavors under the guidance of Denis Fortier. Expressing gratitude to key figures such as Jean-Michel CARLE, Hervé Duchesne de Lamotte, and the Board of Eurobio Scientific, Bosc also acknowledges the trust bestowed by Grégoire Sentilhes and the NextStage AM teams.

This move positions Bosc as a vital mover and shaker in the dynamic landscape of Eurobio Scientific, signalling an exciting chapter of collaboration and achievement. With anticipation and appreciation, Bosc embraces the challenges ahead, ready to make impactful strides in advancing the company's objectives. The synergy of leadership and trust sets the stage for a period of innovation and success under Bosc's capable leadership.

«« NHS Trials an AI System Aimed at Preventing Avoidable Admissions

Physicians Unite to Address and Combat Moral Injury »»

Chief Executive Officer, Olivier Bosc, Eurobio Scientific

Latest Articles

Decision-Making in the ICU
- Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

Chief Executive Officer, Olivier Bosc, Eurobio Scientific Olivier Bosc embarks on an exhilarating journey as the newly appointed Deputy Chief Executive Officer at Eurobio Scientific, eager to contribute to the co...